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Cell death by apoptosis plays a key role in skin devel-
opment and homeostasis. Previous studies have shown 
that increased apoptosis characterizes several patho-
logic conditions affecting human skin. Thus, the path-
ogenesis of cutaneous diseases may involve an imbal-
ance in the homeostatic mechanisms determining 
whether the death of keratinocytes will occur by ter-
minal differentiation or apoptosis. We investigated the 
involvement of apoptosis in psoriasis. For this purpose, 
we assessed, in addition to morphology and DNA frag-
mentation, the expression of two putative apoptotic 
genes, bc1-2 and "tissue" transglutaminase, in normal 
and psoriatic skin. A large number of keratinocytes 
showing biochemical and morphologic features of 
cells undergoing apoptosis was observed in all the su-
prabasallayers of the psoriatic epidermis. The plaques 
from all patients analyzed showed a dramatic reduc-
D espite the increasing number of studies, the patho-genesis of psoriasis remains unclear [1]. Cell death plays a fundamental role in skin.developmen~ and i~1 the regulation of cell numbers 111 mature epidermis [2,3] . Cell death by apoptosis, which shares several 
structural and regulatory events with keratinocyte death by termi-
nal differentiation, is active in removing excessive and abnormal 
cells from the epidermis [2-5]. A current important topic in. skin 
biology is the understanding of how autonomous and/or envlro~­
mental signals determine whether the death of post-mitotic keratl-
nocytes occurs by terminal differentiation or by apopt~SlS [4,5] .  A 
large number of genetic, cellular, and biochel!llcal studies have 111-
dicated that several genes must be expressed 111 a strictly regulated 
manner to allow a cell to die in a way compatible with physiologic 
conditions [3] . According to their distinct roles within the cell death 
program, the ~utative apoptotic ~e~es can be classified into three 
different functlonal groups: permiSSive, regulatory, and effector el-
ements [6]. A key role in the initiation of apoptosis is played by 
proto-oncogenes such as c{os and c-myc, as well as by the tumor 
suppressor gene p53 [7 - 9]. The product of the b~I-2 gene [10,11], 
in association with a family of recently charactenzed related genes 
[12], has emerged as a suppressi,:e e lemen~ of the ~e.ll death pr~­
gram; i.e., a block ofbcl-2 expressIOn IS reqUired to Imtlate apoptosls 
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tion in the number ofbcl-2 - positive cells localized in 
the basal cell compartment. In contrast, the psoriatic 
lesions presented a marked induction in "tissue" 
transglutaminase, which was localized specifically to 
the cytoplasm of apoptotic keratinocytes. "Tissue" 
transglutaminase protein staining was undetectable in 
normal epidermis. The bcl-2 and "tissue" transgluta-
minase staining pattern observed in psoriasis also was 
found in the skin of patients affected by lichen planus. 
These findings indicate that these two genes are regu-
lated in an opposite fashion in psoriatic keratinocytes 
undergoing apoptosis, thus confirming their antithetic 
role in the cascade of events leading to the establish-
ment of the mature apoptotic phenotype. Key words: 
lichen planus/psoriasis/programmed cell death/melanocytes/ 
DNAfragmentation.] Invest DermatoI103:8Z9-833, 1994 
[11] . Among the genes identified recently as effector elements of the 
apoptotic cell death program are those coding for the Ca++-depen-
dent enzymes "tissue" transglutaminase (tTG) and endonuclease 
[3,12,13]. Transglutaminases are a family of intracellular and extra-
cellular enzymes that catalyze Ca++-dependent reactions establish-
ing e(y-glutamyl)lysine bonds and/or di- and polyamines derived 
cross-linkages into proteins [3,12]. The tTG gene is expressed in 
cells undergoing apoptosis in various in vivo and in vitro contexts 
[3,14,!5]. Overexpression of tTG in Balb/c 3T3 fibroblasts pro-
duces 111 the transfected cells the cytoplasmic changes characteristic 
of apoptosis [16]. tTG activation in the dying cells leads to the 
formation of intracellular protein polymers insoluble in detergents 
and. chaotroplc ~g~nts [3,1 2]. Another biochemical event occurring 
dunng apoptosls IS cleavage of the DNA at the internucleosomal 
linker regions [3,13]. 
Morphologic studies have shown that an increased number of 
apoptotic cells characterizes several pathologic conditions affecting 
mature human skin, such as lichen planus, Darier's disease, "sun-
burn cells," graft-versus-host reactions, and tumors [2,4,5,15 -19]. 
In this report, we demonstrate that in psoriatic patients an abnormal 
bcl-2 and tTG expression, indicative of an increased apoptotic rate, 
parallels the typical hyperplastic syndrome. . 
MATERIALS AND METHODS 
Chemicals Streptavidin-biotin immunoperoxidase staining systems were 
obtained from Biogcnex (San Ramon, CA). Other chemicals were of reagent 
grade and used without further purification. 
Antibodies The human red blood cell-soluble tTG antibody was kindly 
provided by Prof. Laszlo Fesus (Dcpartmcnt of Biochemistry, University 
Medical School of Debrecen, Hungary). The anti-human keratinocyte 
transglutaminase antibody was a gift of Prof. Renata Polakowska (Depart-
0022-202Xj94jS07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. 
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Figure 1. Characterization of the specificity of bcl-2 expression in 
normal human skin. Western blotting analysis was carried out on total 
protein extracts (approximately 100 J.lg, latze 1, and 50 J.lg, lane 2) prepared 
from normal human skin and subjected to SDS-PAGE as described previ-
ously [16] . Arrows, relative positions of the molecular weight standards. 
ment of Dermatology, University of Rochester). The monoclonal anti-hu-
man oncoprotein bcl-2 was purchased from Dako. The OKT6 anti-human 
CDl and the anti-human leukocyte antigen (HLA)-DR antibodies were 
obtained from Ortho Diagnostic (Milano, Italy). 
Skin Biopsies Human skin biopsy specimens were obtained from five 
chronic plaque-type untreated psoriatic patients and quickly placed into the 
fixative fluid (Bouin's). After 10 min, pieces of the skin were cut and further 
fixed in Bouin's solution for an additional 4 - 6 h. Additional samples from 
the same psoriatic plaques were frozen rapidly in liquid nitrogen and subse-
quently stored at - 80·C until used. Identical procedures werc used for 
healthy human skin and lichen planus specimcns as normal and pathologic 
controls. 
Western Blotting For Western blotting analysis, aliquots of total protein 
extracts from normal human skin werc electrophoresed (sodium dodecylsul-
fate-polyacrylamide gel electrophoresis [SDS-PAGE], 12.5% acrylamide; 
Fig 1), blotted on Hybond-ECL nitrocellulose filters (Amcrsham, Bucks, 
UK), and staincd, using as primary antibody the mousc monoclonal anti-
bcl-2 antibody (Dako, Denmark) as described previously [16]. 
Immunohistochemistry and DNA Nick End Labeling Immunohis-
tochcmical staining of human skin was performed using the following as 
primary antibodies: affinity-purified monospecific IgG raised in rabbits 
against human red blood cell-soluble tTG (1 : 100), which docs not cross-
react with othcr transglutaminases [3,14]; monoclonal mouse anti-human 
oncoprotein bcl-2 (1 : 40) (Dako); spccific anti-human "keratinocyte" 
transglutarninase (TGI) antibody (1: 100); and anti-human OKT6 and 
anti - HLA-DR antibodics (1: 50) (Ortho) . Incubations with the primary 
antibody wcre carried out in a wet chambcr overnight at 4· C. A biotinylated 
goat anti-rabbit and mouse were used as sccond antibody IgG, followed by a 
preformed streptavidin-horseradish peroxidase complex (Biogenex). The 
reaction was developed using aminoethylcarbazole as chromogen substrate 
and 0.01 % H 20 2 • Cells were counterstained in Mayer's hematoxylin. En-
dogenous peroxidase activity was blocked by methanol-H20 2 • Biopsy speci-
mens were fixed in 4% paraformaldehyde for 15 min at room temperature 
and then were washed extensively in phosphate-buffered saline. Terminal 
deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling 
(TUNEL) was performed as described by Gavrieli et al [20] with few modifi-
cations. Endogenous peroxidase was inactivated using 3% H20 2 for 15 min 
at room temperature; slides then were incubated in terminal deoxynucleoti-
dyl transferase buffcr containing: terminal deoxynucleotidyl transferase (0.5 
cU/ml), biotinylatcd-dUTP (0.025 nmol/J.ll), and CoCl2 (2.5 mM) for 
60 min at 37 ·C in a humid atmosphere. The reaction was blocked by trans-
ferring the slides to TB buffer (300 mM sodium chloride, 30 mM sodium 
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citrate) for 15 min at room temperature. Thc cclls wcre rinsed in distilled 
watcr, covered with 2% aqucous solution of bovine serum albumin for 
10 min, and then immersed in phosphate-buffcred saline for 5 min. The 
slides were covered with peroxidase-col~ugated streptavidin (BioGenex), 
incubated for 20 min, and stain cd with aminoethylcarbazole for 10 min. 
RESULTS AND DISCUSSION 
The morphologic analysis of psoriatic skin revealed many keratino-
cytes showing chromatin and cytoplasmic condensation typical of 
cells undergoing apoptosis [4,5]. To verify whether these morpho-
logic changes were associated with the expression of putative apop-
totic genes such as bcl-2 and tTG, we conducted a systematic inves-
tigation of their expression in five patients. 
Proliferation in the epidermis is limited to the basal cell compart-
ment, where a subset of cells, the stem elements, is responsible for 
maintaining its own number as well as balancing proliferation with 
cell loss by terminal differentiation [19] . Modification in the rate of 
terminal differentiation is not involved in the control of skin cell 
numbers, which instead seem to be regulated by apoptosis [5,19]. As 
reported recently [21], bcl-2 protein was expressed in all cells local-
ized in the basal layer of normal human epidermis (Fig 2). In con-
trast, in the psoriatic plaques we noted a drastic reduction in bcl-2 in 
the proliferative cell compartment, and the protein was present only 
in a subset of cells showing a spindle-like morphology (compare Fig 
2A and 3A). These bcl-2-positive cells were localized regularly 
along the basal cell layer and were not stained by the OKT6 and 
HLA-DR antibodies (Table I). The absence ofHLA-DR and CD1a 
expression and their exclusive location in the basal cell compart-
ment and not in the suprabasal layers led us to identify them as 
melanocytes; by contrast, Langerhans cells normally are spread 
through the suprabasallayers and usually are positive for HLA-DR 
and CD1a (Fig 3A; Table I). 
To verify whether bcl-2 down-regulation is typical of psoriasis or 
is present in other cutaneous disorders involving apoptosis, we in-
vestigated its expression in the skin of patients affected by lichen 
planus (Fig 2). Immunohistochemical analysis indicated that re-
duced expression ofbcl-2 also was present in the basal cell compart-
ment of these patients (Fig 2C). However, in unaffected skin from 
the same patients, the bcl-2 staining pattern was identical to that 
found in normal epidermis (Fig 2A,E). Bcl-2 is considered to be a 
survival but not a mitogenic factor that is expressed mainly in the 
stem cell compartments [10,11,21 ,22]. In keeping with this, the 
drastic reduction in the number of bcl-2 - positive cells observed in 
the basal layer of psoriatic epidermis suggests the involvement of 
undifferentiated keratinocytes in the disease. 
To substantiate this hypothesis further, we investigated the local-
ization of tTG protein in psoriatic patients (Fig 3B.D). In normal 
epidermis, the reaction with the tTG antibody was limited to a few 
scattered cells showing apoptotic morphology and to the endothe-
lial cells in the dermis (Table I). In contrast, in all psoriatic patients 
studied, intense staining was detected in the upper epidermal cell 
layers (Fig 3B.D). The reaction with the tTG antibody was partic-
ularly intense in cells showing the morphologic features of apopto-
sis (Fig 3D). Similar results were obtained in the lesional skin of 
lichen planus (Fig 2D), whereas the bcl-2 and tTG staining pattern 
observed in unaffected skin from psoriatic patients was identical to 
that found in normal skin (data not shown). 
To confirm the specificity of the tTG staining pattern, we studied 
the localization of the membrane-bound TGI, which is important 
in the assembly of cornified envelopes in differentiating keratino-
cytes [23,24]. In psoriasis, in contrast with the results for tTG, TGI 
was localized specifically on the plasma membrane of all suprabasal 
keratinocytes (Fig 3E), thus confirming previous observations 
showing abnormal expression ofTGI in psoriasis [25]. By using the 
TUNEL staining of DNA breaks, we detected a large number of 
cells showing chromatin fragmentation throughout all cell layers in 
psoriatic epidermis (Fig 3F). Taken together, these findings 
strongly indicate that in psoriatic lesions, many keratinocytes un-
dergo apoptosis. 
In recent studies on human skin development, we demonstrated 
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Figure 2. Bcl-2 and tTG: abnormal localization in lichen planus versus normal and unaffected human epidermis. N ormal or lichen planus (both 
unaffected and lesional) skin was biopsied and stained with bcl-2 or anti-tTG antibodies as described in Materials alld Methods. A ) Bcl-210ca.lization in the basal 
layer of normal epidermis. B) Staining of normal epidermis with the anti-tTG antibody. C) Higher magnification ofbcl-2 - positive cells in lesional skin from 
lichen planus. D) Cells stained by the tTG antibody were present in all suprabasallayers of the affected skin from lichen planus. No changes in the bcl-2 (E) and 
tTG (F) staining pattern with respect to the normal epidermis were detected in unaffected skin from the patient with lichen planus (compare with C and D, 
respectively). Bars, A.B,F. 20 jim; C,E. 7 jim. 
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Figure 3. Bcl-2 down-regulation in the basal layer of psoriatic epidermis is paralleled by DNA fragmentation; tTG and TGI increase in the 
suprabasal epidermal layers. Psoriatic lesional skin was biopsied and stained with bcl-2, anti-tTG, and anti-TGI antibodies and examined by TUNEL for 
DNA fragmentation as described in Materials and Methods. A) Note the marked reduction in the number of cells stained by the bcl-2 antibody in the basal layer of 
psoriatic epidermis when compared with normal skin (compare with Fig 2A). By contrast, a large number of cells stained by the tTG antibody was present in 
the suprabasallayers of the affected skin from the same patient (B; compare with Fig 2B) . C) Higher magnification ofbcl-2 -positive cells in the basal cell 
compartment of a psoriatic patient. D) Higher magnification of tTG-positive cells in the suprabasal cell layers of epidermis from a psoriatic patient. Note that 
the staining by the tTG antibody was localized in phenotypically typical apoptotic cells showing condensed cytoplasm and pyknotic chromatin. B) TGI was 
localized on the plasma membrane of all the suprabasal cells of psoriatic epidermis. F) TUNEL staining of psoriatic plaques showed several nuclei with 
fragmented chromatin in all suprabasal epidermal layers, but no staining in the dermis. Bars, A,B, 40 Jim; C,D, 7 Jim; B,P, 20 Jim. 
VOL. 103, NO.6 DECEMBER 1994 
Table I. Bcl-2 and tTG Reactivity in Normal Human 
Skin, Lichen Planus, and Psoriatic Plaque Samples 
Normal Lichen 
Skin Planus Psoriasis 
Bcl-2 tTG Bcl-2 tTG Bcl-2 tTG 
Epidermis 
Basal keratinocytc + 
CD1-/DR- dentritic cell + + + 
CD1+/DR+ dentritic cell 
Suprabasal keratinocyte + + 
Hair follicle 
Outer root sheath + + 
Inner root sheath 
Cortex-cuticle ND' ND 
Bulge area + + 
Matrix + + 
Dermal papilla + + 
Glands 
Eccrine + + + 
Apocrine ± ± ± 
Sebaceous 
Dermal cells 
Fibroblast 
Endothelial cell + + + 
Smooth muscle cell ± ± ± 
Schwalm cell + + + 
Lymphocyte ± ± ± 
Histiocyte 
Neutrophil 
• NO, not done. 
that the different transglutaminases are expressed in a stage-specific 
manner during epidermal mo~phogenesi.s. confirming their ~pecific 
functions [23]. tTG is active III apoptoSlS of relatively undifferen-
tiated keratinocytes. whereas T~I is ~xpressed in th~ terminally 
differentiated cells of mature epidermis l23.24]. The 1l1tense tTG 
staining we observed in the keratinocytes localized in the upper 
layers of the epidermis in both psoriasis and lichen planus strongly 
suggests that these cells are committed to the apoptotic pathway. In 
keeping with these findings. the amount ofNIN8-Bis(y-glutamyl)-
spermidine cross-link was demonstrated. to. be a?normally higher. in 
cornified envelopes extracted from psonatlc sk1l1 as compared with 
normal skin [26]. It is interesting that this polyamine-derived cross-
link stabilizes the detergent-insoluble polymers formed in cells un-
dergoing apoptosis [12] . 
The reduced bcl-2 expression detected in the basal layer of psori-
atic skin indicates that this phenomenon originates in the stem cell 
compartment. It is tempting to speculate that in psoriasis. a large 
number of apoptotic cells can originate from stern cells prematurely 
recruited to reenter the cell cycle but programmed to persist in a 
quiescent Go state. In psoriatic patients. the nu~ber of proliferating 
versus post-mitotic quiescent cells is largely 1l1creased because of 
abnormal shortening of the cell cycle [19.21]. Furthermore. psori-
atic keratinocytes can be primed to undergo apoptosis by various 
factors (growth factors. cytokines. etc.) produced by dendritic or 
immune cells present in the dermis. In agreement with this. psori-
atic skin lesions overproduce IL-6 [27]. which recently has been 
shown to upregulate tTG gene expression [28]. 
In conclusion. our results offer new insight into the pathogenesis 
of psoriasis. suggesting a central role for apoptosis. In psoriasis. as 
observed in other hyperproliferative syndromes. increased apoptosis 
could be a homeostatic mechanism to counteract the overproduc-
tion of cells [3.13]' This hypothesis is consistent with the emerging 
idea that it is not possible to induce proliferation in a cell without 
activating its potential for apoptosis l29]. 
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